Thank you for Subscribing to Life Science Review Weekly Brief
Pharma, biotech, and medical device companies depend on bioanalytical services to advance discovery and provide innovative therapies to patients.
FREMONT, CA: Finding a completely automated bioanalytical laboratory is difficult, but doing so might help drug makers remain competitive in the current market. A completely automated laboratory can conduct regulated and error-free experiments, vastly boosting the precision and productivity of both preclinical and clinical programs. Bringing a medicine to market is a labor and time-intensive process. Automating operations during bioanalysis can increase assay precision, timetable dependability, and analytical performance. Automation is a dynamic method for directing the entire procedure.
Enhancing consistency and management
Automation ensures consistency throughout several phases, including sample preparation, reagent storage, and compound identification. An automated bioanalytical laboratory can process at least ten plates in the same amount of time. In addition, error margins can be significantly lower through automated apps that perform repetitive activities and data entry. Robotic applications execute liquid manipulation, incubation, plate washing, and other tasks. Automatic data collection and output improve data acquisition, enhanced labor processes, data analysis, and sample management.
Automation results in more robust schedules
A fully automated bioanalytical laboratory produces higher quality results and improves program schedules. Bioanalysis assays take up to two weeks when performed manually, although automation can decrease this to a couple of days. The improved quality assays and data inherent to automation also meet regulatory compliance standards. By streamlining sample analysis, automated bioanalytical laboratories can expedite the Investigational New Drug (IND) and Biologics License Application (BLA) processes. Bioanalysts can conduct additional tests while awaiting the automated findings of an earlier set.
Partners capable of enabling automation
Not every laboratory has adopted or constructed fully automated techniques. But the advantages of automating assays, such as eliminating human error, reducing costs, and shortening schedules, can be game-changing. Companies need to ask partners how their facilities utilize industry-leading technology to enhance their programs as soon as possible. Bioanalytical services offer a comprehensive array of R&D that enable pharmaceutical industry enterprises with innovative therapies. As an innovation-driven and customer-centric business, it assists partners in enhancing healthcare productivity by providing cost-effective, efficient, socially responsible, and sustainable solutions.